C12Y 114/99
Miscellaneous
Official title: Miscellaneous (1.14.99)
C12Y114/99 (Miscellaneous) appears on 111 US grants and 173 published applications in this corpus.
Search patents in C12Y- Granted patents
- 111
- Published applications
- 173
- Assignees
- 115
- Inventors
- 413
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 3 |
| 2003 | 2 | 6 |
| 2004 | 2 | 5 |
| 2005 | 0 | 4 |
| 2006 | 2 | 2 |
| 2007 | 0 | 2 |
| 2008 | 0 | 5 |
| 2009 | 2 | 2 |
| 2010 | 1 | 6 |
| 2011 | 2 | 2 |
| 2012 | 5 | 4 |
| 2013 | 2 | 3 |
| 2014 | 4 | 7 |
| 2015 | 2 | 15 |
| 2016 | 5 | 5 |
| 2017 | 7 | 9 |
| 2018 | 5 | 8 |
| 2019 | 8 | 9 |
| 2020 | 2 | 6 |
| 2021 | 6 | 12 |
| 2022 | 3 | 11 |
| 2023 | 7 | 10 |
| 2024 | 12 | 22 |
| 2025 | 7 | 8 |
| 2026 | 6 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 114/99001Prostaglandin-endoperoxide synthase , i.e. cyclooxygenase45
- C12Y 114/99003Heme oxygenase16
- C12Y 114/99009Steroid 17-alpha-monooxygenase , i.e. cytochrome-p450-steroid-17-alpha-hydroxylase10
- C12Y 114/99007Squalene monooxygenase8
- C12Y 114/9901Steroid 21-monooxygenase , i.e. steroid cytochrome p450 21-hydroxylase5
- C12Y 114/99045,6-dimethylbenzimidazole synthase2
- C12Y 114/990233-hydroxybenzoate 2-monooxygenase1
- C12Y 114/99033Delta12-fatty acid dehydrogenase1
All 37 subgroupsShow fewer
- C12Y 114/99034Monoprenyl isoflavone epoxidase1
- C12Y 114/99038Cholesterol 25-hydroxylase1
- C12Y 114/99045Carotene epsilon-monooxygenase1
- C12Y 114/99002Kynurenine 7,8-hydroxylase0
- C12Y 114/99004Progesterone monooxygenase0
- C12Y 114/99011Estradiol 6-beta-monooxygenase0
- C12Y 114/99012Androst-4-ene-3,17-dione monooxygenase0
- C12Y 114/99014Progesterone 11-alpha-monooxygenase0
- C12Y 114/990154-methoxybenzoate monooxygenase0
- C12Y 114/99019Plasmanylethanolamine desaturase0
- C12Y 114/9902Phylloquinone monooxygenase0
- C12Y 114/99021Latia-luciferin monooxygenase , i.e. latia luciferase0
- C12Y 114/99022Ecdysone 20-monooxygenase0
- C12Y 114/99024Steroid 9-alpha-monooxygenase0
- C12Y 114/990262-hydroxypyridine 5-monooxygenase0
- C12Y 114/99027Juglone 3-monooxygenase0
- C12Y 114/99029Deoxyhypusine monooxygenase0
- C12Y 114/99031Myristoyl-coa 11- desaturase0
- C12Y 114/99032Myristoyl-coa 11- desaturase0
- C12Y 114/99035Thiophene-2-carbonyl-coa monooxygenase0
- C12Y 114/99036Beta-carotene 15,15'-monooxygenase0
- C12Y 114/99037Taxadiene 5-alpha-hydroxylase0
- C12Y 114/99039Ammonia monooxygenase0
- C12Y 114/99041All-trans-8'-apo-beta-carotenal 15,15'-oxygenase0
- C12Y 114/99042Zeaxanthin 7,8-dioxygenase0
- C12Y 114/99043Beta-amyrin 24-hydroxylase0
- C12Y 114/99044Diapolycopene oxygenase0
- C12Y 114/99046Pyrimidine oxygenase0
- C12Y 114/99047-larreatricin hydroxylase0
Recent patents
- Genetic engineering of fungi to modulate tryptamine expression22 Sep 2026US 12,742,160 B2Empyrean Neuroscience, Inc.
- Cardiac-specific targeting-peptide (CTP), compositions, and uses thereof2 Jun 2026US 12,643,924 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance26 May 2026US 12,637,690 B2eGenesis, Inc.
- Cells, tissues, organs, and animals having one or more modified genes for enhanced xenograft survival and tolerance19 May 2026US 12,630,838 B2eGenesis, Inc.
- Production of lipids and terpenoids in Auxenochlorella protothecoides5 May 2026US 12,618,088 B2Phycoil Biotechnology International, Inc.
- Compositions and methods for the treatment of sepsis13 Aug 2026US 2026/0234635 A1
- Compositions and methods for treating pulmonary conditions6 Aug 2026US 2026/0224499 A1Mayo Foundation for Medical Education and Research
- Nitrification inhibitors30 Jul 2026US 2026/0215425 A1
- Production of canthaxanthin30 Jul 2026US 2026/0218213 A1Amyris, Inc.
- Microbial production of triterpenoids including mogrosides21 May 2026US 2026/0139286 A1Manus Bio Inc.
Most cited
By later US patents
- Somatic gene therapy to cells associated with fluid spaces87US 5,770,580 ABaylor College of Medicine · 1998
- Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity55US 5,543,297 AMerck Frosst Canada, Inc. · 1996
- Tranformation of cells associated with fluid spaces45US 5,792,751 ABaylor College of Medicine · 1998
- Method of inhibiting prostaglandin synthesis in a human host34US 6,048,850 A2000
- Microbial production of natural sweeteners, diterpenoid steviol glycosides26US 9,284,570 B2Massachusetts Institute of Technology · 2016